Stoke Therapeutics (STOK) PT Raised to $60 at Canaccord
(Updated - March 20, 2026 6:58 AM EDT)
Canaccord analyst Sumant Kulkami raised the price target on Stoke Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Canaccord analyst Sumant Kulkami raised the price target on Stoke Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
